NEW YORK, March 6 (GenomeWeb News) - Tripos shares were down 9.37 percent, or $.31, in afternoon trade after Tripos announced a 20-percent slip in revenues for the fourth quarter and a net loss of $5.2 million.
As GenomeWeb News reported this morning, the company attributed the fall-off to the winding down of a four-year, $90 million file enrichment project with Pfizer.